Back
For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".
To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".
During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center.
Preparing your E-Poster
Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.
E-Poster Submission Deadline
Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.
Please follow the instructions below to input your abstract title.
Abstract titles should be brief and reflect the content of the abstract.
Development of acute kidney injury (AKI) in the community is associated with hospitalisations, risk of progression to chronic kidney disease (CKD) and patient mortality. Certain medications increase the risk of AKI during acute illness, including sulfonylureas, angiotensin converting enzyme inhibitors (ACEi), diuretics, metformin, angiotensin receptor blockers (ARBs), non-steroidal anti-inflammatories drugs (NSAIDS), and sodium glucose co-transporter 2 (SGLT2) inhibitors (SADMANS medications). The KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of CKD recommends temporary cessation of these medications through sick day medication guidance (SDMG). Despite this, evidence indicates that <15% of clinicians provide SDMG. Since no Australian studies have evaluated SDMG use in practice, the aim of this study is to evaluate healthcare professionals' (HCPs) SDMG practices, including frequency, contents and delivery modes of SDMG, and compare perceptions of SDMG between different professions.
A cross-sectional survey was conducted among Australian registered medical practitioners, nurses and pharmacists. Descriptive statistics were generated using Excel and qualitative data underwent conventional content analysis. Comparison of perceptions was done using Kruskal–Wallis followed by Dunn’s post-hoc tests with Holm correction.
Of 113 surveys that were collected, 89 were included for analysis. Participants included medical practitioners (n=23, 25.8%), nurses (n=29, 32.6%) and pharmacists (n=37, 41.6%). Participants specialised in general practice (n=28, 28%), nephrology (14, 14.0%), with 33 participants (37.1%) having >20 years of clinical experience.
While 90% (n=80) of participants believed SDMG is important, 73% (n=65) reported providing it. Frequency of provision varied by medication class: “often” for diuretics, NSAIDS and SGLT2 inhibitors and “sometimes” for sulfonylureas, ACEi, metformin and ARBs.
SDMG was typically provided to select, high-risk patients (n=47, 72.3%) and was mostly provided through verbal counselling (n=52, 80.0%) and written sick day action plan (n=40, 61.5%). Advice regarding, “lifestyle advice including rest and keeping up with hydration”, “when to withhold medications”, “when to recommence medications” and “monitoring” was most consistently provided for diuretics and SGLT2 inhibitors. Patient factors which HCPs considered included patient language, health literacy, cognition, education and baseline adherence to medications.
Broadly, two implementation barriers emerged. The first was lack of integration into the healthcare system, largely due to organisational issues including workload, time constraints, access to laboratory tests, unclear roles of each HCP and poor interprofessional communication and collaboration. The second barrier was the inadequate patient resources, particularly the limited availability and suitability of education materials.
Notable differences in SDMG prioritisation and goals were observed between pharmacists and nurses.
HCPs recognise the importance of SDMG and are willing to provide it but face organisational barriers to consistent implementation. Addressing these challenges through clearer workplace guidelines, multidisciplinary coordination and tailored educational materials are needed to embed SDMG into routine care. Further research is also needed to evaluate real-world outcomes of providing SDMG to better support uptake.
